Related Experiment Video
Updated: Oct 17, 2025

Author Spotlight: Investigating the Pathophysiology of Eosinophilic Esophagitis
Published on: May 10, 2024
Exophiala dermatitidis
Daisuke Usuda1, Toshihiro Higashikawa2, Yuta Hotchi3
1Department of Emergency and Critical Care Medicine, Juntendo University Nerima Hospital, Nerima-ku 177-8521, Tokyo, Japan. d.usuda.qa@juntendo.ac.jp.
Abstract:
Exophiala is a genus comprising several species of opportunistic black yeasts, which belongs to Ascomycotina. It is a rare cause of fungal infections. However, infections are often chronic and recalcitrant, and while the number of cases is steadily increasing in both immunocompromised and immunocompetent people, detailed knowledge remains scarce regarding infection mechanisms, virulence factors, specific predisposing factors, risk factors, and host response. The most common manifestations of Exophiala infection are skin infections, and the most frequent type of deep infection is pulmonary infection due to inhalation. The invasive disease ranges from cutaneous or subcutaneous infection to systemic dissemination to internal organs. The final identification of the causative organism should be achieved through a combination of several methods, including the newly introduced diagnostic analysis, matrix-assisted laser desorption/ionization-time-of-flight mass spectrometry, together with sequencing of the ribosomal ribonucleic acid internal transcribed spacer region of the fungi, and histological and culture findings. Regarding treatment, because anti-infective agents and natural compounds exhibited poor antibiofilm activity, few treatments have ultimately been found to be effective for specific antifungal therapy, so the optimal antifungal therapy and duration of therapy for these infections remain unknown. Therefore, most forms of disease caused by Exophiala dermatitidis require aggressive combination therapies: Both surgical intervention and aggressive antifungal therapy with novel compounds and azoles are necessary for effective treatment.
Insights
Exophiala black yeasts cause rare but chronic fungal infections in immunocompromised and immunocompetent individuals. Effective treatment requires aggressive combination therapies, including surgery and novel antifungal agents.
Area of Science:
- Mycology
- Infectious Diseases
- Medical Mycology
Background:
- Exophiala, an opportunistic black yeast, causes increasingly common, chronic, and recalcitrant fungal infections.
- Infections manifest primarily as cutaneous or pulmonary disease, with potential for systemic dissemination.
- Knowledge gaps exist regarding Exophiala infection mechanisms, virulence, and host responses.
Discussion:
- Accurate diagnosis relies on a combination of MALDI-TOF MS, ITS sequencing, histology, and culture.
- Current antifungal agents and natural compounds show poor antibiofilm activity, limiting treatment options.
- Optimal antifungal therapy and duration for Exophiala infections remain undetermined.
Key Insights:
- Exophiala infections are rising in both immunocompromised and immunocompetent populations.
- Pulmonary infections are the most frequent deep-seated manifestation.
- Aggressive combination therapy, including surgery and novel antifungals (azoles), is crucial for treatment.
Outlook:
- Further research is needed to elucidate infection mechanisms and host responses.
- Development of novel antifungal compounds with antibiofilm activity is essential.
- Standardized treatment protocols for Exophiala infections require establishment.
Related Concept Videos
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Bacterial Phylum Spirochaetes
Bacterial Phylum Chlamydiae
Diversity of Protists I
Hyperthermophilic Bacteria
Bacterial Phylum Actinobacteria

